Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART

Vaccine. 2010 Feb 10;28(6):1606-12. doi: 10.1016/j.vaccine.2009.11.045. Epub 2009 Dec 2.

Abstract

Humoral immune response to vaccine antigens is known to be reduced in perinatally HIV-infected children. Lymphocyte immunophenotyping, humoral immunity to hepatitis B after primary immunization and response to revaccination were evaluated in 40 HIV-infected adolescents on HAART and 23 healthy age-matched controls. Anti-HBs antibody levels >or=10 mIU/mL were found in 18/40 (40.5%) of the HIV-infected adolescents and 18/23 (78.3%) of the HIV-negative adolescents from Control group. Adolescents of HIV group with anti-HBs>or=1 0 mIU/mL presented a higher CD4+ T cell percentage, higher naïve and central memory CD8+ T cell percentages and lower immune activation markers. After revaccination, 12/18 (66.7%) adolescents of HIV group responded. Those adolescents who did not respond to revaccination presented a lower CD4+ T cell percentage, higher immune activation markers and more frequently detectable HIV viral load. We concluded that lower immune activation, higher CD4+ T cell percentage and better control of HIV replication may be associated with hepatitis B vaccine response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antiretroviral Therapy, Highly Active*
  • CD4-CD8 Ratio
  • CD8-Positive T-Lymphocytes / immunology
  • Child
  • HIV / isolation & purification
  • HIV Infections / drug therapy
  • HIV Infections / transmission*
  • Hepatitis B Antibodies / blood
  • Hepatitis B Vaccines / immunology*
  • Hepatitis B virus / immunology*
  • Humans
  • Immunization, Secondary*
  • Immunologic Memory*
  • Infectious Disease Transmission, Vertical*
  • Time Factors
  • Viral Load
  • Young Adult

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Vaccines